JPH0698917A - Ultrasonic cell membrane matching vibration treatment of malignant tumor - Google Patents

Ultrasonic cell membrane matching vibration treatment of malignant tumor

Info

Publication number
JPH0698917A
JPH0698917A JP29365792A JP29365792A JPH0698917A JP H0698917 A JPH0698917 A JP H0698917A JP 29365792 A JP29365792 A JP 29365792A JP 29365792 A JP29365792 A JP 29365792A JP H0698917 A JPH0698917 A JP H0698917A
Authority
JP
Japan
Prior art keywords
frequencies
cells
cancer cells
cell membrane
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP29365792A
Other languages
Japanese (ja)
Inventor
Takao Kawamura
隆夫 河村
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RYOJU SHOJI KK
Original Assignee
RYOJU SHOJI KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RYOJU SHOJI KK filed Critical RYOJU SHOJI KK
Priority to JP29365792A priority Critical patent/JPH0698917A/en
Publication of JPH0698917A publication Critical patent/JPH0698917A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Percussion Or Vibration Massage (AREA)

Abstract

PURPOSE:To prohibit the growth of malignant tumors and eventually to reduce and kill the malignant tumors by regarding the malignant tumors as the assemblage of individual elastic bodies each having a membrane structure and selectively irradiating the peripheral parts of the tumor cells with ultrasonic waves near the resonance frequencies possessed by the tumor cells. CONSTITUTION:This treatment method prohibits oxygen activity and kills the cancer cells by irradiating the lesions with the ultrasonic waves of the frequencies matched with the frequencies of the cancer cells, thereby losing the transmittability of the cell membranes of the cancer cells. More specifically, the three-dimensional ultrasonic irradiation treatment method of the composite frequencies using the composite frequencies of low frequencies and high frequencies is used. Specimens are first taken out of a part of the cancer cells and the characteristics of the cells are measured by a resonance frequency analyzer and thereafter, the frequencies are determined at the time of the treatment of a patient 6 of the progressive cancer transferred with the cancers 7 over the entire part of the body. The patient 6 is then put into a bath tub 5 contg. a physiological salt soln. 9 kept at about 37 deg.C and is irradiated with the composite frequencies generated by sound wave oscillating sources 8... for about two to three hours, by which the treatment is executed.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は,例えば医療分野におけ
る,悪性腫瘍に対する,より効果的な超音波治療法に関
し,詳しくは人体の各部位の細胞を異なった固有振動数
を有する膜構造の弾性体群として,各細胞群の持つ固有
の周波数特性を活かした超音波治療法及び超音波健康増
進法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a more effective ultrasonic treatment method for malignant tumors, for example, in the medical field, and more specifically to the elasticity of a membrane structure having different natural frequencies for cells of each part of the human body. As a body group, the present invention relates to an ultrasonic treatment method and an ultrasonic health promotion method that make use of the unique frequency characteristics of each cell group.

【0002】[0002]

【従来の技術】従来,超音波を用いた悪性腫瘍,即ち癌
の治療法としては,超音波を用いた温熱療法が中心であ
った。超音波発振体の振動子から放射されるエネルギー
が体内の腫瘍部分にて減衰される時に生じる発熱を利用
したものである。これらは主に人体の正常細胞と癌細胞
との高温に対する耐熱性の違いに着目,癌細胞が正常細
胞より僅かに熱体性が低い事を応用したものである。
2. Description of the Related Art Conventionally, as a method of treating a malignant tumor using ultrasonic waves, that is, cancer, hyperthermia using ultrasonic waves has been the main focus. It utilizes the heat generated when the energy emitted from the oscillator of the ultrasonic oscillator is attenuated at the tumor part in the body. They mainly focus on the difference in heat resistance between normal cells and cancer cells in the human body against high temperatures, and apply the fact that cancer cells have slightly lower thermophysical properties than normal cells.

【0003】しかしながら,今までの超音波治療法では
単に温熱効果にのみ捕らわれて,正常細胞と癌細胞との
僅かな耐熱性の違いしか利用されていなかった。
However, in the ultrasonic treatment methods up to now, only a slight difference in heat resistance between normal cells and cancer cells has been utilized because it is caught only by the hyperthermic effect.

【0004】[0004]

【発明が解決しようとする課題】本発明が解決しようと
する問題点は,超音波を用いて,人体にできた癌細胞を
正常細胞に与える影響を最小にして,尚且つ選択的に癌
化された細胞だけを効率的に,少なくとも成長阻害さ
せ,さらに死滅させる方法を提供することにある。
The problem to be solved by the present invention is to use ultrasonic waves to minimize the effect of cancer cells formed in the human body on normal cells, and to selectively transform cancerous cells. It is intended to provide a method for efficiently inhibiting at least growth and killing only the killed cells.

【0005】[0005]

【課題を解決するための手段】本願の第一発明は,癌細
胞の持つ特異性に着目することにある。癌細胞は正常細
胞と比較して,細胞膜の状態に特異性があり,細胞膜の
強度,細胞の大きさ,弾力性に違いが見いだせる。これ
により人体の細胞を弾性体と見なした場合,正常細胞と
癌細胞とでは,その固有振動数,即ち外界から音圧によ
る刺激を与えた場合の正常細胞と癌細胞の各細胞の共振
周波数が異なることになる。弾性体はその共振周波数付
近にて外界から振動エネルギーを受けた時が,最も効果
的に,大きな振動を行うことが知られている。従って癌
細胞が共振周波数付近にて外界より振動エネルギーを受
けた場合,その細胞膜は最も大きく運動し,そのエネル
ギーの強さによっては,膜を形成する脂質分子の生理作
用を破壊し,細胞膜の透過性を失わせ,膜に結合してい
る酵素の活性を失わせる事が可能になる。さらに癌細胞
に与える共振エネルギーを増加させれば,その細胞膜を
破壊することも可能となる。また共振周波数付近でエネ
ルギーの減衰が最大となることから温熱効果の併用も高
効率となることが期待できる。
The first invention of the present application is to focus on the specificity of cancer cells. Cancer cells have specificity in the state of the cell membrane as compared to normal cells, and differences in cell membrane strength, cell size, and elasticity can be found. As a result, when the cells of the human body are regarded as elastic bodies, the natural frequencies of the normal cells and the cancer cells, that is, the resonance frequencies of the normal cells and the cancer cells when stimulated by sound pressure from the outside are given. Will be different. It is known that the elastic body vibrates most effectively when it receives vibration energy from the outside in the vicinity of its resonance frequency. Therefore, when a cancer cell receives vibrational energy from the outside in the vicinity of the resonance frequency, its cell membrane moves most, and depending on the intensity of the energy, it destroys the physiological action of the lipid molecule forming the membrane and permeates the cell membrane. It becomes possible to lose the activity and the activity of the enzyme bound to the membrane. Furthermore, if the resonance energy given to the cancer cells is increased, the cell membrane can be destroyed. Further, since the attenuation of energy is maximized near the resonance frequency, it is expected that the combined use of the thermal effect will be highly efficient.

【0006】具体的な治療においては,まず患者の癌患
部の癌細胞を採取,同時に周辺の正常細胞の採取を行
い,これらの標本を反射率測定装置等を用いて,その患
者個人の,その細胞個々の固有振動数,即ち共振周波数
を測定することにより始まる。癌細胞と周辺部位正常細
胞及び超音波治療を行う場合の照射経路上の正常細胞の
共振周波数を測定した後は,癌細胞の共振周波数におけ
る治療効果を得る為の超音波放射エネルギー強度と正常
細胞に対する安全限度を実験及び理論的に割り出す。こ
れにより割り出された周波数が該当する患者を治療する
ための周波数となる。癌が転移して複数ケ所存在する場
合は,当然,治療に要する周波数も,それぞれ異なった
周波数を用いる場合が生じる。また患者より直接標本を
採取できないような場合は,外部より患部にパルス音波
信号を照射した時の患部の周波数応答特性より,癌細胞
の其振周波数を推定する事もできる。
In specific treatment, first, cancer cells in a cancerous part of a patient are sampled, and at the same time, peripheral normal cells are sampled, and these samples are sampled by using a reflectance measuring device or the like. It starts by measuring the natural frequency of each cell, that is, the resonance frequency. After measuring the resonance frequency of the cancer cells and normal cells in the surrounding area and normal cells on the irradiation path when performing ultrasonic treatment, the ultrasonic radiation energy intensity and normal cells for obtaining the therapeutic effect at the resonance frequency of the cancer cells Experimentally and theoretically determine the safety limit for. The frequency thus determined becomes the frequency for treating the corresponding patient. When the cancer has metastasized and exists at multiple sites, it is natural that different frequencies are used for treatment. When a sample cannot be taken directly from the patient, the oscillation frequency of the cancer cells can be estimated from the frequency response characteristics of the affected part when a pulsed sound wave signal is applied to the affected part from the outside.

【0007】治療の仕方は,通常の超音波治療法と同様
に,超音波振動子を,水,流動パラフィン,オリーブ
油,ヒマシ油などの脱気した液体を媒体として用い,投
射部位の体表面に密着させて照射を行うか,患者が脱気
した液体の入った風呂のような治療器の中に浸かり照射
を行うか,患者の手術中に患部に直接照射する場合や,
口腔部分には,ケーブル先端に取り付けた超音波振動子
を挿入して照射を行う等の方法がある。
The method of treatment is the same as in the ordinary ultrasonic treatment method, in which an ultrasonic transducer is used as a medium with degassed liquid such as water, liquid paraffin, olive oil, castor oil, etc. When the irradiation is performed in close contact, when the patient is soaked in a treatment device such as a bath filled with degassed liquid for irradiation, or when the patient is directly irradiated on the affected area during surgery,
There are methods such as inserting an ultrasonic transducer attached to the tip of the cable into the oral cavity for irradiation.

【0008】本願の第二発明は,第一の発明の概念を拡
大し,細菌等の徴生物に対しても同様な処理方法を提供
している。液体中の細菌等に対しても,微小物体の持つ
弾性体としての特性と表面膜の生理作用の特性を利用す
ることにより,液体中の,細胞や細菌等の持つ弾性体と
しての共振周波数に相当する超音波を照射することによ
り,目的とする対象集団のみを選択的に死滅させる方法
である。
The second invention of the present application expands the concept of the first invention and provides a similar treatment method for biological organisms such as bacteria. Even for bacteria etc. in liquid, the resonance frequency as an elastic body of cells and bacteria in liquid can be determined by utilizing the characteristics of microscopic objects as an elastic body and the characteristics of physiological action of surface membrane. This is a method of selectively killing only the target group of interest by irradiating the corresponding ultrasonic waves.

【0009】本願の第三発明は,人体の正常細胞が各々
有する共振周波数で,正常細胞に危害が及ばない程度の
十分に微弱なエネルギーの超音波振動を人体に照射する
ことによって,細胞膜に刺激をあたえて細胞膜の生理活
性を高めるものである。
The third invention of the present application is to stimulate the cell membrane by irradiating the human body with ultrasonic vibration of sufficiently weak energy that does not harm normal cells at the resonance frequency of each normal cell of the human body. To increase the physiological activity of the cell membrane.

【0010】[0010]

【作用】本発明においては,超音波照射を従来のように
温熱効果として用いるだけでなく,主に癌細胞の細胞膜
に最大の運動エネルギーを与えることによって,成長阻
害,死滅を行うため,また弾性体としての正常細胞と癌
細胞との共振周波数Qの違いを利用し,各々の患者の個
々の癌細胞に合わせた周波数の超音波を選択して用いる
ことにより,効率的に目標の治療を行うことができる。
また比較的弱い照射エネルギーにて治療が可能なため,
いわゆるキャビテーション現象も避けることができ,ま
た人体の深部に対しては収束超音波として投射すること
により効果は更に向上する。また正常細胞に封し,その
共振周波数付近で微弱な超音汲を照射した場合は,細胞
膜が適度に刺激され,各細胞の新陳代謝が促進される。
In the present invention, not only is ultrasonic irradiation used as a conventional thermal effect, but growth inhibition and death are achieved mainly by giving maximum kinetic energy to the cell membrane of cancer cells. By utilizing the difference in resonance frequency Q between normal cells and cancer cells as the body and selecting and using ultrasonic waves with a frequency that matches the individual cancer cells of each patient, the target treatment is efficiently performed. be able to.
In addition, because it is possible to treat with relatively weak irradiation energy,
The so-called cavitation phenomenon can be avoided, and the effect can be further improved by projecting a focused ultrasonic wave into the deep part of the human body. When the cells are sealed in normal cells and irradiated with a weak ultrasonic wave near their resonance frequency, the cell membrane is moderately stimulated and the metabolism of each cell is promoted.

【0011】[0011]

【実施例】図1は,細胞内の膜構造のモデル図である。
癌細胞にマッチングした周波数の超音波を患部に照射す
ることにより,癌細胞の細胞膜の透過性を失わせ酵素活
性を阻害し,癌細胞を死に至らしめることになる。1,
2は蛋白質分子で1は親水部分,2は疎水部分,3,4
は細胞膜の脂質分子で3は親水部分,4は疎水部分であ
る。
EXAMPLE FIG. 1 is a model diagram of the intracellular membrane structure.
By irradiating the affected area with ultrasonic waves having a frequency matched with the cancer cells, the permeability of the cell membrane of the cancer cells is lost, the enzyme activity is inhibited, and the cancer cells are killed. 1,
2 is a protein molecule, 1 is a hydrophilic part, 2 is a hydrophobic part, 3, 4
Is a lipid molecule of the cell membrane, 3 is a hydrophilic part, and 4 is a hydrophobic part.

【0012】[0012]

【発明の効果】本発明は,主には癌の超音波応用治療に
おいて,今まで余り問題にされていなかった弾性体とし
ての癌細胞との周波数のマッチングと言うことに着目
し,さらには癌の治療メカニズムを癌の細胞膜の過大振
動,運動による透過性阻害に置いたことで,より安全で
効率の良い,さらに反復治療のしやすい治療法を提供し
た。人体の構造は複雑であり,本発明にて全ての癌の治
療に適応することは困難な事ではあるが,数多くの癌患
者の本治療実績が蓄積されるに従い,超音波治療におけ
る周波数と照射強度の関係,さらには癌細胞膜の透過性
阻害との関係,照射方法等が明確になり,超音波治療の
領域に更なる進歩をもたらすものとなる。
INDUSTRIAL APPLICABILITY The present invention focuses on the frequency matching with cancer cells as an elastic body, which has not been a problem so far in ultrasonic treatment of cancer, and further, By placing the therapeutic mechanism of the above in the excessive vibration of the cell membrane of cancer and the obstruction of permeability due to movement, we provided a safer, more efficient, and more repeatable treatment method. Although the structure of the human body is complicated and it is difficult to apply the present invention to the treatment of all cancers, the frequency and irradiation in ultrasonic treatment will increase as the actual treatment results of many cancer patients accumulate. The strength relationship, the relationship with the permeability inhibition of the cancer cell membrane, the irradiation method, etc. will be clarified, which will bring further progress in the field of ultrasonic therapy.

【0013】[0013]

【図面の簡単な説明】[Brief description of drawings]

【図1】細胞内の膜構造のモデル図FIG. 1 Model of intracellular membrane structure

【符号の説明】[Explanation of symbols]

1 蛋白質分子 親水部分 2 蛋白質分子 疎水部分 3 細胞膜の脂質分子 親水部分 4 細胞膜の脂質分子 疎水部分 1 protein molecule hydrophilic part 2 protein molecule hydrophobic part 3 cell membrane lipid molecule hydrophilic part 4 cell membrane lipid molecule hydrophobic part

─────────────────────────────────────────────────────
─────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成4年10月2日[Submission date] October 2, 1992

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】特許請求の範囲[Name of item to be amended] Claims

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【特許請求の範囲】[Claims]

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0006[Correction target item name] 0006

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0006】 具体的な治療においては,まず患者の癌
患部の癌細胞を採取,同時に周辺の正常細胞の採取を行
い,これらの標本を反射率測定装置等を用いて,その患
者個人の,その細胞個々の固有振動数,即ち共振周波数
を測定することにより始まる。癌細胞と周辺部位正常細
胞及び超音波治療を行う場合の照射経路上の正常細胞の
共振周波数を測定した後は,癌細胞の共振周波数におけ
る治療効果を得る為の超音波放射エネルギー強度と正常
細胞に対する安全限度を実験及び理論的に割り出す。こ
れにより割り出された周波数が該当する患者を治療する
ための周波数となる。癌が転移して複数ケ所存在する場
合は,当然,治療に要する周波数も,それぞれ異なった
周波数を用いる場合が生じる。また患者より直接標本を
採取できないような場合は,外部より患部にパルス音波
信号を照射した時の患部の周波数応答特性より,癌細胞
の共振周波数を推定する事もできる。また本願の第四発
明による方法は癌細胞の比較的安定した中間期ではな
く,不安定な分裂期を狙い,数十Hzから数百キロHz
といった比較的低周波数の音波を適宜な時間,単一発振
源ではなく,少なくとも二次元方向から,好ましくは三
次元方向から,患部あるいは全身に照射することによ
り,癌細胞の分裂期の細胞膜を破壊させるものである。
音波の照射は低周波数と高周波数の音波を複合して照射
すれば更に好ましい。複合周波数照射はさらに対応範囲
を広めることができる。低周波の音波は体内での減衰が
少なく,身体の深部にまで,効果的に到達し,三次元方
向からの照射は,癌細胞に三次元運動を起こさせ,通常
細胞に障害を与えることなく,癌細胞の分裂時期にのみ
分裂阻害効果を与え,癌細胞の成長阻害,縮小,死滅を
行う。また分裂期の癌細胞を攻めることにより,比較的
弱いエネルギー照射にて治療を行うことが可能になり,
安全面も更に向上する。いかなる場合においても,本発
明による治療には,常に患者の照射前,照射中,照射後
の状況変化をモニターしながら進められ,音波照射が体
内に悪影響を及ぼさぬ様に安全面は常に管理される。ま
た音波照射を受ける患者に対し,栄養剤の投与,抗癌剤
の投与等を併用することができる。
[0006] In specific treatment, first, cancer cells of a patient's cancer affected area are collected, and at the same time, peripheral normal cells are collected, and these specimens are sampled by using a reflectance measuring device or the like. It starts by measuring the natural frequency of each cell, that is, the resonance frequency. After measuring the resonance frequency of the cancer cells and normal cells in the surrounding area and normal cells on the irradiation path when performing ultrasonic treatment, the ultrasonic radiation energy intensity and normal cells for obtaining the therapeutic effect at the resonance frequency of the cancer cells Experimentally and theoretically determine the safety limit for. The frequency thus determined becomes the frequency for treating the corresponding patient. When the cancer has metastasized and exists at multiple sites, it is natural that different frequencies are used for treatment. When a sample cannot be directly collected from the patient, the resonance frequency of the cancer cells can be estimated from the frequency response characteristics of the affected part when a pulsed sound wave signal is externally applied to the affected part. In addition, the fourth issue of the present application
The method by Ming is not a relatively stable interphase of cancer cells.
A few tens to several hundreds of kilohertz, aiming for an unstable mitotic period
Single oscillation of sound waves of relatively low frequency such as
Not at the source, but at least in two dimensions, preferably three
By irradiating the affected area or the whole body from the dimensional direction
Therefore, it destroys the cell membrane of the cancer cell in the mitotic phase.
Sound waves are emitted by combining low-frequency and high-frequency sound waves.
It is more preferable to do so. Combined frequency irradiation is also available
Can be spread. Low frequency sound waves are attenuated in the body
A few, effective to reach deep inside the body, three-dimensional
Directional irradiation causes cancer cells to undergo three-dimensional movement, usually
Only at the time of division of cancer cells without damaging cells
It gives a mitotic inhibitory effect on the growth inhibition, shrinkage and death of cancer cells.
To do. By attacking cancer cells in the mitotic phase,
It is possible to treat with weak energy irradiation,
The safety aspect is further improved. In any case
Always treat patients with light before, during, and after irradiation.
Sound wave irradiation is performed while monitoring the changes in
The safety aspect is always managed so as not to have an adverse effect on the inside. Well
Of nutritional supplements and anti-cancer drugs to patients undergoing sonic irradiation
Can be used in combination.

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0007[Correction target item name] 0007

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0007】 治療の仕方は,通常の超音波治療法と同
様に,超音波振動子を,水,流動パラフィン,オリーブ
油,ヒマシ油などの脱気した液体を媒体として用い,投
射部位の体表面に密着させて照射を行うか,患者が脱気
した液体の入った風呂のような治療器の中に浸かり照射
を行うか,患者の手術中に患部に直接照射する場合や,
口腔部分には,ケーブル先端に取り付けた超音波振動子
を挿入して照射を行う等の方法がある。超音波の照射エ
ネルギーは通常の超音波治療に用いられる範囲より小さ
いエネルギーにて使用され,特に共振点よりやや外れた
低周波帯を用いる治療法は患者を体温前後の温度に設定
された生理食塩等の入った浴槽にいれ,周囲より全身に
適度に弱い音波を長時間繰り返し照射を行うことによ
り,癌細胞の比較的脆弱な細胞分裂の時期を狙って分裂
を阻害し,一部の進行癌にも有効性が期待される治療法
である。
As in the case of the usual ultrasonic treatment method, the ultrasonic wave is used on the body surface of the projection site by using an ultrasonic transducer as a medium of degassed liquid such as water, liquid paraffin, olive oil, castor oil, etc. When the irradiation is performed in close contact, when the patient is soaked in a treatment device such as a bath filled with degassed liquid for irradiation, or when the patient is directly irradiated on the affected area during surgery,
There are methods such as inserting an ultrasonic transducer attached to the tip of the cable into the oral cavity for irradiation. Ultrasonic irradiation
Energy is below the range used for conventional ultrasound therapy
Used at high energy, especially slightly off resonance
Treatment method using low frequency band sets patient to temperature around body temperature
Put it in the bathtub containing the physiological saline, etc.
By applying moderately weak sound waves repeatedly for a long time,
And aim at the relatively fragile stage of cell division in cancer cells
Therapies that inhibit cancer and are expected to be effective in some advanced cancers
Is.

【手続補正4】[Procedure amendment 4]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0010[Correction target item name] 0010

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0010】[0010]

【作用】 本発明においては,超音波照射を従来のよう
に温熱効果として用いるだけでなく,主に癌細胞の細胞
膜に最大の運動エネルギーを与えることによって,成長
阻害,死滅を行うため,また弾性体としての正常細胞と
癌細胞との共振周波数Qの違いを利用し,各々の患者の
個々の癌細胞に合わせた周波数の超音波を選択して用い
ることにより,効率的に目標の治療を行うことができ
る。また比較的弱い照射エネルギーにて治療が可能なた
め,いわゆるキャビテーショシ現象も避けることがで
き,また人体の深部に対しては収束超音波として投射す
ることにより効果は更に向上する。更に,低周波数帯を
用い,比較的弱い照射エネルギーで,少なくとも二次元
方向から,全身に長時間の繰り返し照射を行へば,比較
的不安定な,癌細胞の細胞分裂時期に細胞膜に障害を与
え,分裂阻害による癌細胞の成長減退,退縮,死滅効果
も期待できる。また正常細胞に対し,その共振周波数付
近で微弱な超音波を照射した場合は,細胞膜が適度に刺
激され,各細胞の新陳代謝が促進される。
In the present invention, not only is ultrasonic irradiation used as a conventional thermal effect, but growth inhibition and death are achieved mainly by giving maximum kinetic energy to the cell membrane of cancer cells. By utilizing the difference in resonance frequency Q between normal cells and cancer cells as the body and selecting and using ultrasonic waves with a frequency that matches the individual cancer cells of each patient, the target treatment is efficiently performed. be able to. In addition, since the treatment can be performed with relatively weak irradiation energy, so-called cavitation phenomenon can be avoided, and the effect is further improved by projecting as a focused ultrasonic wave on the deep part of the human body. Furthermore, the low frequency band
With relatively weak irradiation energy, at least two-dimensional
From the direction, if the whole body is repeatedly irradiated for a long time, comparison
Unstable, impairs the cell membrane during the cell division of cancer cells
Efficacy of cancer cell growth reduction, regression, and death due to mitotic inhibition
Can be expected . When normal cells are irradiated with weak ultrasonic waves near their resonance frequency, the cell membrane is moderately stimulated and the metabolism of each cell is promoted.

【手続補正5】[Procedure Amendment 5]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0011[Correction target item name] 0011

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0011】[0011]

【実施例】 図1は,細胞内の膜構造のモデル図であ
る。癌細胞にマッチングした周波数の超音波を患部に照
射することにより,癌細胞の細胞膜の透過性を失わせ酵
素活性を阻害し,癌細胞を死に至らしめることになる。
1,2は蛋白質分子で1は親水部分,2は疎水部分,
3,4は細胞膜の脂質分子で3は親水部分,4は疎水部
分である。図2は,低周波と高周波の複合周波数を用い
た複合周波数の三次元音波照射療法である。全身に癌が
転移した進行癌の患者に対し,一部の癌細胞からは検体
を取り出し,水晶振動子を用いた共振周波数分析機に
て,その細胞の特性を測定し,その他の検体取り出しの
困難な部位の癌に対しては低周波を重点に照射を行う。
浴槽の生理食塩水の温度は約37度Cとし,照射時間は
20分程度から開始し,患者の血圧,その他の容体を見
ながら増加させ,最終的には2時間から3時間/回とす
る。使用周波数は低周波側は100Hzから10kHz
帯を用い,高周波側は1MHzから10MHz帯を用い
る。照射エネルギーは0.1W/cm程度から始め,患
者の容体を見ながら人体の正常部分に障害を与えない範
囲にて逐次増加させる。患者は音波治療の前には栄養剤
等を投与し,また音波治療後には抗癌剤を投与をしてい
る。患者は定期的に癌患部の断層写真により治療による
効果を確認,評価しながら,治療を続行する。図3は肝
臓癌の患者に対する治療例である。患者の癌患部の検体
より治療周波数と放射強度を決め治療を行う。放射時間
と放射強度は安全設定ラインの50%以下より始め逐
次,患者の容体を見ながら増加させる。
EXAMPLES FIG. 1 is a model diagram of the intracellular membrane structure. By irradiating the affected area with ultrasonic waves having a frequency matched with the cancer cells, the permeability of the cell membrane of the cancer cells is lost, the enzyme activity is inhibited, and the cancer cells are killed.
1, 2 are protein molecules, 1 is a hydrophilic part, 2 is a hydrophobic part,
3 and 4 are lipid molecules of the cell membrane, 3 is a hydrophilic part and 4 is a hydrophobic part. Figure 2 uses a combination of low and high frequencies
3D sonication with multiple frequencies. Cancer in the whole body
Samples from some cancer cells for patients with metastatic advanced cancer
The resonance frequency analyzer using a crystal unit.
Then, the characteristics of the cells are measured and other specimens are taken out.
Irradiation is focused on low frequencies for cancer in difficult areas.
The temperature of the saline solution in the bathtub is about 37 degrees C, and the irradiation time is
Start from about 20 minutes and check the patient's blood pressure and other conditions.
While increasing, and finally 2 to 3 hours / time
It The operating frequency is 100 Hz to 10 kHz on the low frequency side.
Band, high frequency side uses 1MHz to 10MHz band
It Irradiation energy starts from about 0.1 W / cm
While looking at the condition of the person, a range that does not impair the normal part of the human body
It increases sequentially in the circle. Patient should be a nutritional supplement before sonication
, Etc., and the anticancer drug was administered after the sonication.
It Patients are regularly treated by tomography of the affected area
Continue treatment while confirming and evaluating the effect. Figure 3 shows the liver
This is an example of treatment for a patient with spleen cancer. Sample of patient's cancer affected area
The treatment frequency and radiant intensity are determined and the treatment is performed. Radiation time
And radiant intensity start from below 50% of the safety setting line
Next, increase while watching the patient's condition.

【手続補正6】[Procedure correction 6]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】図2[Name of item to be corrected] Figure 2

【補正方法】追加[Correction method] Added

【補正内容】[Correction content]

【図2】浴槽による超音波全身照射治療の例図であるFIG. 2 is an example diagram of ultrasonic whole body irradiation treatment in a bath .

【手続補正7】[Procedure Amendment 7]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】図3[Name of item to be corrected] Figure 3

【補正方法】追加[Correction method] Added

【補正内容】[Correction content]

【図3】局部癌の治療例図であるFIG. 3 is a diagram showing an example of treatment of local cancer .

【手続補正8】[Procedure Amendment 8]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】符号の説明[Correction target item name] Explanation of code

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【符号の説明】 1 蛋白質分子 親水部分 2 蛋白質分子 疎水部分 3 細胞膜の脂質分子 親水部分 4 細胞膜の脂質分子 疎水部分5 浴槽 6 治療を受ける患者 7 癌患部 8 音波発振源 9 生理食塩水 10 患者の踏み格子 11 床 12 脱気水を入れた袋 [Explanation of symbols] 1 protein molecule hydrophilic part 2 protein molecule hydrophobic part 3 lipid molecule of cell membrane hydrophilic part 4 lipid molecule of cell membrane hydrophobic part 5 bath 6 patient to be treated 7 cancer affected area 8 sound wave source 9 saline 10 patient's Trampling grid 11 floor 12 bag containing deaerated water

【手続補正9】[Procedure Amendment 9]

【補正対象書類名】図面[Document name to be corrected] Drawing

【補正対象項目名】図2[Name of item to be corrected] Figure 2

【補正方法】追加[Correction method] Added

【補正内容】[Correction content]

【図2】 [Fig. 2]

【手続補正10】[Procedure Amendment 10]

【補正対象書類名】図面[Document name to be corrected] Drawing

【補正対象項目名】図3[Name of item to be corrected] Figure 3

【補正方法】追加[Correction method] Added

【補正内容】[Correction content]

【図3】 [Figure 3]

【手続補正書】[Procedure amendment]

【提出日】平成4年10月8日[Submission date] October 8, 1992

【手続補正1】[Procedure Amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】請求項4[Name of item to be corrected] Claim 4

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【手続補正2】[Procedure Amendment 2]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0006[Correction target item name] 0006

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0006】 具体的の治療においては,まず患者の癌
患部の癌細胞を採取,同時に周辺の正常細胞の採取を行
い,これらの標本を反射率測定装置等を用いて,その患
者個人の,その細胞個々の固有振動数,即ち共振周波数
を測定することにより始まる。癌細胞と周辺部位正常細
胞及び超音波治療を行う場合の照射経路上の正常細胞の
共振周波数を測定した後は,癌細胞の共振周波数におけ
る治療効果を得る為の超音波放射エネルギー強度と正常
細胞に対する安全限度を実験及び理論的に割り出す。こ
れにより割り出された周波数が該当する患者を治療する
ための周波数となる。癌が転移して複数ケ所存在する場
合は,当然,治療に要する周波数も,それぞれ異なった
周波数を用いる場合が生じる。また患者より直接標本を
採取できないような場合は,外部より患部にパルス音波
信号を照射した時の患部の周波数応答特性より,癌細胞
の共振周波数を推定する事もできる。また本願の第四発
明による方法は癌細胞の比較的安定した中間期ではな
く,不安定な分裂期を狙い,数十Hzから数百キロHz
といった比較的低周波数の音波を適宜な時間,単一発振
源ではなく,少なくとも相対する二次元方向から,好ま
しくは三次元方向から,患部あるいは全身に照射するこ
とにより,癌細胞の分裂期の細胞膜を破壊させるもので
ある。音波の照射は低周波数と高周波数の音波を複合し
て照射すれば更に好ましい。複合周波数照射はさらに対
応範囲を広めることができる。低周波の音波は体内での
減衰が少なく,身体の深部にまで,効果的に到達し,三
次元方向からの照射は,癌細胞に三次元の圧縮,膨張
動を起こさせ,通常細胞に障害を与えることなく,癌細
胞の分裂時期にのみ分裂阻害効果を与え,癌細胞の成長
阻害,縮小,死滅を行う。また分裂期の癌細胞を攻める
ことにより,比較的弱いエネルギー照射にて治療を行う
ことが可能になり,安全面も更に向上する。いかなる場
合においても,本発明による治療には,常に患者の照射
前,照射中,照射後の状況変化をモニターしながら進め
られ,音波照射が体内に悪影響を及ぼさぬ様に安全面は
常に管理される。また音波照射を受ける患者に対し,栄
養剤の投与,抗癌剤の投与等を併用することができる。
[0006] In specific treatment, first, cancer cells in a cancer affected area of a patient are collected, and at the same time, normal cells around the cancer cells are collected, and these specimens are sampled by using a reflectance measuring device or the like. It starts by measuring the natural frequency of each cell, that is, the resonance frequency. After measuring the resonance frequency of the cancer cells and normal cells in the surrounding area and normal cells on the irradiation path when performing ultrasonic treatment, the ultrasonic radiation energy intensity and normal cells for obtaining the therapeutic effect at the resonance frequency of the cancer cells Experimentally and theoretically determine the safety limit for. The frequency thus determined becomes the frequency for treating the corresponding patient. When the cancer has metastasized and exists at multiple sites, it is natural that different frequencies are used for treatment. When a sample cannot be directly collected from the patient, the resonance frequency of the cancer cells can be estimated from the frequency response characteristics of the affected part when a pulsed sound wave signal is externally applied to the affected part. The method according to the fourth invention of the present application aims at an unstable mitotic phase of cancer cells, rather than at a relatively stable intermediate phase, and aims at several tens to several hundreds of kilohertz
Appropriate time a relatively low frequency of the acoustic wave such, rather than a single oscillation source, at least opposite the two-dimensional direction, preferably from the three-dimensional directions, by irradiating the affected part or whole body, cell membrane mitotic cancer cells To destroy. It is more preferable to irradiate sound waves by irradiating sound waves of low frequency and high frequency in combination. Multiple frequency irradiation can further expand the range of coverage. Low-frequency sound waves are not attenuated in the body and effectively reach deep inside the body. Irradiation from three-dimensional directions causes cancer cells to undergo three-dimensional compression and expansion. , It gives a mitotic inhibitory effect only at the time of division of cancer cells without damaging normal cells, and inhibits growth, shrinkage, and death of cancer cells. By attacking cancer cells in the mitotic phase, it becomes possible to treat with relatively weak energy irradiation, and the safety aspect is further improved. In any case, the treatment according to the present invention is always carried out while monitoring changes in the patient's pre-irradiation, during irradiation, and post-irradiation conditions, and safety is always controlled so that sonic irradiation does not adversely affect the body. It In addition, administration of a nutritional supplement, administration of an anti-cancer drug, etc. can be used in combination for a patient who is subjected to ultrasonic wave irradiation.

【手続補正3】[Procedure 3]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0010[Correction target item name] 0010

【補正方法】変更[Correction method] Change

【補正内容】[Correction content]

【0010】 本発明においては,超音波照射を従来の
ように温熱効果として用いるだけでなく,主に癌細胞の
細胞膜に最大の運動エネルギーを与えることによって,
成長阻害,死滅を行うため,また弾性体としての正常細
胞と癌細胞との共振周波数Qの違いを利用し,各々の患
者の個々の癌細胞に合わせた周波数の超音波を選択して
用いることにより,効率的に目標の治療を行うことがで
きる。また比較的弱い照射エネルギーにて治療が可能な
ため,いわゆるキャピテーション現象も避けることがで
き,また人体の深部に対しては収束超音波として投射す
ることにより効果は更に向上する。更に,低周波数帯を
用い,比較的弱い照射エネルギーで,少なくとも相対す
二次元方向から.全身に長時間の繰り返し照射を行へ
ば,比較的不安定な,癌細胞の細胞分裂時期に細胞膜に
障害を与え,分裂阻害による癌細胞の成長減退,退縮,
死滅効果も期待できる。また正常細胞に対し,その共振
周波数付近で微弱な超音波を照射した場合は,細胞膜が
適度に刺激され,各細胞の新陳代謝が促進される。
In the present invention, not only is ultrasonic irradiation used as a conventional thermal effect, but mainly by giving maximum kinetic energy to the cell membrane of cancer cells,
In order to inhibit growth and kill, and by utilizing the difference in resonance frequency Q between normal cells and cancer cells as elastic bodies, select and use an ultrasonic wave with a frequency that matches the individual cancer cells of each patient The target treatment can be performed efficiently. In addition, since the treatment can be performed with relatively weak irradiation energy, so-called capitation phenomenon can be avoided, and the effect is further improved by projecting as a focused ultrasonic wave on the deep part of the human body. Further, using a low frequency band, a relatively weak irradiation energy, to at least the relative
From the two-dimensional direction. If the whole body is repeatedly irradiated for a long time, the cell membrane is damaged during the cell division stage of the cancer cell, which is relatively unstable, and the growth inhibition and regression of the cancer cell due to the inhibition of division occur.
A killing effect can also be expected. When normal cells are irradiated with weak ultrasonic waves near their resonance frequency, the cell membrane is moderately stimulated and the metabolism of each cell is promoted.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 悪性腫瘍を膜構造を持った個々の弾性体
の集合体と見なし,周辺正常細胞との細胞膜の強度,固
有周波数の相違を利用し,腫瘍細胞の周辺部位に,該当
する腫瘍細胞の持つ共振周波数近傍の超音波を選択照射
することによって,少なくとも該当する腫瘍細胞の細胞
膜を変性させ,さらには細胞膜を破壊させることによ
り,少なくとも悪性腫瘍の成長を阻止させ,さらには縮
小,死滅させることを特徴とする悪性腫瘍の治療方法。
1. A malignant tumor is regarded as an aggregate of individual elastic bodies having a membrane structure, and by utilizing the difference in cell membrane strength and natural frequency from surrounding normal cells, the tumor corresponding to the peripheral part of the tumor cell is identified. By selectively irradiating ultrasonic waves in the vicinity of the resonance frequency of the cells, at least the cell membrane of the relevant tumor cells is denatured, and further, the cell membrane is destroyed, at least the growth of malignant tumors is blocked, and further reduction and death are performed. A method for treating a malignant tumor, which comprises:
【請求項2】 外膜が破壊あるいは変性することによっ
て死滅する性質を有する微小生物体に,この微小生物体
が弾性体として有する固有周波数近傍の音波を選択照射
することにより,種々の固有振動数を有する微小生物体
群より,同一固有周波数を有する徴小生物体群を選択的
に死滅させることを特徴とする徴小生物体の死滅方法。
2. Various natural frequencies can be obtained by selectively irradiating a micro organism having a property of dying when the outer membrane is destroyed or denatured, with a sound wave near the natural frequency that the micro organism has as an elastic body. A method of dying a small organism, which comprises selectively erasing a small organism group having the same natural frequency from a group of small organisms having a.
【請求項3】 人体の各部位の正常細胞が持つ弾性体と
しての固有振動数近傍の超音波を,細胞膜に十分無害な
程度の強度にて各部位に選択照射し,人体の各部位の細
胞膜を適度に刺激し,細胞膜の活性を増大させ新陳代謝
を促進させる事を特徴とする健康増進方法。
3. A cell membrane of each part of a human body by selectively irradiating each part with ultrasonic waves in the vicinity of a natural frequency as an elastic body of a normal cell of each part of the human body A method for promoting health, which is characterized by stimulating the cells appropriately to increase the activity of the cell membrane and promote metabolism.
JP29365792A 1992-09-19 1992-09-19 Ultrasonic cell membrane matching vibration treatment of malignant tumor Withdrawn JPH0698917A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29365792A JPH0698917A (en) 1992-09-19 1992-09-19 Ultrasonic cell membrane matching vibration treatment of malignant tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29365792A JPH0698917A (en) 1992-09-19 1992-09-19 Ultrasonic cell membrane matching vibration treatment of malignant tumor

Publications (1)

Publication Number Publication Date
JPH0698917A true JPH0698917A (en) 1994-04-12

Family

ID=17797563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29365792A Withdrawn JPH0698917A (en) 1992-09-19 1992-09-19 Ultrasonic cell membrane matching vibration treatment of malignant tumor

Country Status (1)

Country Link
JP (1) JPH0698917A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7497119B2 (en) * 1998-09-11 2009-03-03 Gr Intellectual Reserve, Llc Methods and systems for using resonant acousto-EM energy and acousto-EM signatures to disrupt biologic structures
CN105899159A (en) * 2013-09-23 2016-08-24 皇家飞利浦有限公司 Medical apparatus for treating cells with vibrations
CN113229171A (en) * 2021-03-30 2021-08-10 锦州医科大学 Three-dimensional vibration training method for animals and selection method of frequency parameters

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7497119B2 (en) * 1998-09-11 2009-03-03 Gr Intellectual Reserve, Llc Methods and systems for using resonant acousto-EM energy and acousto-EM signatures to disrupt biologic structures
JP2011002463A (en) * 1998-09-11 2011-01-06 Gr Intellectual Reserve Llc Method for using resonant acoustic and/or resonant acoustic-em energy to detect and/or effect structure
CN105899159A (en) * 2013-09-23 2016-08-24 皇家飞利浦有限公司 Medical apparatus for treating cells with vibrations
JP2016536088A (en) * 2013-09-23 2016-11-24 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Medical device for treating cells with vibration
CN113229171A (en) * 2021-03-30 2021-08-10 锦州医科大学 Three-dimensional vibration training method for animals and selection method of frequency parameters

Similar Documents

Publication Publication Date Title
EP1711109B1 (en) Localized production of microbubbles and control of cavitational and heating effects by use of enhanced ultrasound
Sibille et al. Extracorporeal ablation of liver tissue by high-intensity focused ultrasound
Yumita et al. Sonodynamically induced antitumor effect of a gallium‐porphyrin complex, ATX‐70
EP1779891A1 (en) Method of activating a photosensitizer
US20130096595A1 (en) Methods and systems for inducing hyperthermia
Köhrmann et al. Technical characterization of an ultrasound source for noninvasive thermoablation by high‐intensity focused ultrasound
US20090062724A1 (en) System and apparatus for sonodynamic therapy
US20060030798A1 (en) Method for therapeutic action with a ultrasonic field to biological tissues and a device for this purpose
US20230097605A1 (en) Damaging cancerous cells utilizing radio frequency waves in heating with heating enhanced by infusion or injection of glucose
JPH11192231A (en) Ultrasonic treatment device for woman's breast
Sasaki et al. Antitumor effect sonodynamically induced by focused ultrasound in combination with Ga‐porphyrin complex
KR20070094621A (en) Adjuvant of fluorocarbon emulsions for hifu therapy and the use thereof
EP2194579A2 (en) Device for controlling physiological processes in a biological object
EP2645954A1 (en) Apparatus for the treatment of hyperhidrosis
JPH0698917A (en) Ultrasonic cell membrane matching vibration treatment of malignant tumor
Feril et al. Therapeutic potential of low-intensity ultrasound (part 1): thermal and sonomechanical effects
Vranić Sonophoresis-mechanisms and application
CN1298400C (en) Method and equipment for setting medical care device of ultrasound microbubble contrast media to form embolism in capillary vessel
Spirou et al. Development and testing of an optoacoustic imaging system for monitoring and guiding prostate cancer therapies
WO2006030534A1 (en) Integrated system for noninvasive focused energy treatment using energy activated drugs
RU2289386C2 (en) Method of ultrasonic physiotherapy in liquid
RU2341307C1 (en) Method of rehabilitation selective chronophototherapy
Hutchinson et al. Evaluation of an aperiodic phased array for prostate thermal therapies
WO2019186305A1 (en) Transducer assembly
Moussa Liposomal drug release using ultrasound and modeling release dynamics for model predictive controller design

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 19991130